IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 141
Titolo Data di pubblicazione Autore(i) File
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer. 2000 Natoli, Clara; Scognamiglio, M. T.; Martino, M. T.; Irtelli, L.; DE TURSI, Michele; Cianchetti, Ettore; Mascitelli, Elia; Tinari, Nicola; Iacobelli, Stefano
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. 2004 Grassadonia, Antonino; Tinari, Nicola; Fiorentino, B; Suzuki, K; Nakazato, M; DE TURSI, Michele; Giuliani, Cesidio; Napolitano, Giorgio; Singer, Ds; Iacobelli, Stefano; Kohn, L. D.
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding study 2005 Ricevuto, E; Morelli, Mf; Calista, F; Guglielmi, F; Cannita, K; Porzio, G; Rispoli, Ai; Santomaggio, A; Mancini, M; Lanfiuti Baldi, P; Tinari, Nicola; DE TURSI, Michele; Marchetti, P; Ficorella, C.
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study. 2006 Ficorella, C; Ricevuto, E; Morelli, Mf; Morese, R; Cannita, K; Cianci, G; Porzio, G; Di, ; Rocco, Zc; DE GALITIIS, F; DE TURSI, Michele; Tinari, Nicola; Iacobelli, Stefano; Marchetti, P.
A multicenter phase II study of Epirubicin (E) with low-dose Herceptin (LD-H) as a first line treatment in HER-2 overexpressing metastatic breast cancer (MBC): Preliminary Results 2007 DE TURSI, Michele; Carella, C; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, S.
PERITONECTOMIA ED HIPEC NEL TRATTAMENTO DELLA CARCINOSI PERITONEALE: RISULTATI PRELIMINARI DOPO UN ANNO DI ESPERIENZA 2007 Irtelli, L.; Massari, R; Mucilli, Felice; DE TURSI, Michele; Carella, C.; Errichi, Silvia; Marino, F.; Sacco, Rocco
A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer 2007 DE TURSI, Michele; Carella, Consiglia; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, Stefano
A multicenter phase II study of epirubicin (E) with low-dose herceptin (LD-H) as a first-line treatment in HER2 overexpressing metastatic breast cancer (MBC) 2007 De Tursi, M; Carella, C; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, S
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 2007 Natoli, Clara; Cianchetti, Ettore; Tinari, Nicola; Angelucci, D; Grassadonia, Antonino; Zilli, Marinella; Ficorella, C; Ricevuto, E; Grossi, Simona; DE TURSI, Michele; Carella, Consiglia; Rispoli, Ai; Iacobelli, Stefano
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 2007 Iurisci, Ida; Rich, T; Lévi, F; Innominato, Pf; Tinari, Nicola; Irtelli, L; DE TURSI, Michele; Grassadonia, Antonino; Iacobelli, Stefano
Epirubicin plus low-dose trastuzumab in HER2 positivemetastatic breast cancer 2009 Alessandra, Gennari; DE TURSI, Michele; Consiglia, Carella; Enrico, Ricevuto; Cinzia, Orlandini; Antonio, Frassoldati; Pierfranco, Conte; Paolo, Bruzzi; Iacobelli, Stefano
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 2010 DI NISIO, Marcello; Ferrante, Noemi; DE TURSI, Michele; Iacobelli, Stefano; Cuccurullo, Franco; Buller, Hr; Feragalli, Beatrice; Porreca, Ettore
The use of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy(HIPEC) in patients undergoing cytoreductive surgery (CS) for peritoneal carcinomatosis ofovarian origin 2010 DE TURSI, Michele; Salvatorelli, E; Carella, ; Bianco, N; Massari, R; Sacco, R; Menna, P; Minotti, G; Iacobelli, Stefano
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 2010 Ferrante, N; DI NISIO, Marcello; DE TURSI, Michele; Iacobelli, S; Cuccurullo, F; Bϋller, Hr; Porreca, Ettore
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 2010 Ferrante, Noemi; DI NISIO, Marcello; DE TURSI, Michele; Iacobelli, Stefano; Cuccurullo, Franco; Büller, Hr; Porreca, Ettore
PO-06 Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 2010 Ferrante, N.; Di Nisio, M.; De Tursi, M.; Iacobelli, S.; Cuccurullo, F.; Büller, H. R.; Porreca, E.
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 2011 DI NISIO, Marcello; Ferrante, Noemi; Feragalli, Beatrice; DE TURSI, Michele; Iacobelli, Stefano; Cuccurullo, Franco; Porreca, Ettore
Lapatinib in second-line treatment for metastatic breast cancer: rapid clinical benefit and long-term response. 2012 DE TURSI, Michele; Carella, C.
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors 2012 Tinari, Nicola; DE TURSI, Michele; Grassadonia, Antonino; Marinella, Zilli; Stuppia, Liborio; Iacobelli, Stefano; Natoli, Clara
New Targets for Therapy in Pancreatic Cancer 2012 Tinari, Nicola; DE TURSI, Michele; Grassadonia, Antonino; Marinella, Zilli; Iacobelli, Stefano; Natoli, Clara
Mostrati risultati da 1 a 20 di 141
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile